Hemophilia B, characterized by a deficiency in clotting factor IX, presents a challenging yet evolving landscape in the field of hematology. This rare genetic disorder predominantly affects males and necessitates ongoing advancements in treatment modalities to improve patient outcomes worldwide. Dive into comprehensive analysis! Purchase the complete report @ Hemophilia B Market Understanding...